Aristotle University Of Thessaloniki (AUTH)
Η δράση της αλαντικής τοξίνης στη συντηρητική θεραπεία και ανάταξη των οστικών καταγμάτων: πειραματική μελέτη σε επίμυες
Abstract
dc:descriptionThe present study aims to explore the action of botulinum neurotoxin A in the conservative management of fractures. Two experiments were carried out on rats and results were published in peer-reviewed journal. This is a novel study, with limited relevant data available in the literature. One of the fundamental principles in fracture healing is the maintenance of stability, which is not only related to immobilisation but also to the action of muscles that can cause displacement of bone fragments. For reasons explained below, it was decided to induce fractures to the midshaft of the clavicle on Wistar rats. The first experimental study aimed to determine the minimum safe dose of botulinum toxin to result in paralysis of the sternocleidomastoid muscle for 28 days after intramuscular administration. Injection was administered under direct vision and paralysis was studied using electromyography. The data collected in the first experiment was used in the second study, in which animals were divided into four groups, according to the presence or absence of fracture and the administration or not of toxin. This study aimed to investigate the effects of the toxin on the fracture as well as the muscle. On the 28th postoperative day and following euthanasia of the animals, radiological and histopathological assessment of the bone to evaluate the healing process and tissue. Findings indicated that intramuscular administration of botulinum toxin was not beneficial in the healing of clavicle fractures. Moreover, the histological review of the tissue revealed degeneration of the muscle. In conclusion, this study determined the minimum safe dose of botulinum toxin that can result in paralysis of the sternocleidomastoid muscle in rats for 28 days. Moreover, it showed that the toxin has no benefit in the conservative management of fractures, while its application can result in adverse changes in the muscle. These outcomes should be taken into consideration by researchers and clinicians when utilising the toxin, whether in cosmetic (BoTox) or therapeutic applications (spasticity, cerebral palsy, etc).
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vampertzis, Themistoklis
- Βαμπερτζής, Θεμιστοκλής
Subjects
dc:subject × 14- Αλλαντική τοξίνη
- Πώρωση κατάγματος
- Μυϊκή παράλυση
- Ορθοπαιδικό Τραύμα
- Botulinum toxin type A
- Fracture healing
- Muscle paralysis
- Orthopaedic trauma
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58877